English
English
简体中文
0760-89920979
Home
About Us
Our Team
Pipeline
News
Company news
Industry news
Join Us
Contact Us
0760-89920979
News
Home
>
News
/
Company news
/
09-23
2026
Rabpharma's RAB-202 Granted FDA Rare Pediatric Disease Designation!
View More>
07-24
2026
UC Davis Distinguished Prof. Kit S. Lam Visited Rabpharma for Technical Exchange on Peptide Therapeutics
View More>
06-05
2026
Prof. Wei Yao Presented New Findings at 2026 OARSI World Congress on Osteoarthritis
View More>
04-21
2026
First Participant Enrolled in Phase 1b Trial of RAB001d for Knee Osteoarthritis
View More>
04-21
2026
Now Recruiting Participants: Phase 1b Clinical Trial of RAB001d for Knee Osteoarthritis
View More>
1
2
3
4
5
6
0760-89920979
info@rabpharma.com
